Meglumine, also known as N-Methyl-D-glucamine or Methylglucamine, is a pharmaceutical-grade organic compound derived from D-glucitol (sorbitol). It belongs to the amino sugar family and is used in pharmaceutical formulations, particularly in the preparation of salts of certain acidic pharmaceutical compounds and diagnostic contrast media.
Meglumine has the CAS Number 6284-40-8, molecular formula C₇H₁₇NO₅, and molecular weight approximately 195.21 g/mol. Its chemical name is 1-Deoxy-1-(methylamino)-D-glucitol.
Meglumine is a polyhydroxy compound containing an amino group. Its chemical structure contributes to its water solubility and ability to form salts with certain acidic substances. It is commonly used as a counterion in pharmaceutical compounds and as a component of selected contrast-media formulations.
Pharmaceutical reference information describes Meglumine as a white crystalline powder. It is freely soluble in water, slightly soluble in ethanol and practically insoluble in diethyl ether.
Meglumine has several pharmaceutical applications:
Its function depends on the specific formulation and the active compound with which it is combined.
Meglumine is listed in the United States Pharmacopeia–National Formulary (USP-NF). The USP monograph defines its assay requirement as not less than 99.0% and not more than 100.5%, calculated on the dried basis.
Additional quality tests include identification, assay, residue on ignition, absence of reducing substances, and completeness and color of solution. These tests help assess the identity, purity and quality of pharmaceutical-grade Meglumine.
For pharmaceutical procurement, the current official USP monograph, approved material specification and batch-specific Certificate of Analysis (COA) should be reviewed. The applicable USP edition should be confirmed before finalizing release criteria.
Meglumine should be stored in suitable, well-closed packaging under the conditions specified by the approved product documentation. Packaging should protect the material from contamination and unsuitable environmental exposure. Always follow the manufacturer's storage instructions and batch-specific COA.
1. What is Meglumine?
Meglumine is an organic pharmaceutical compound also known as N-Methyl-D-glucamine or Methylglucamine.
2. What is the CAS number of Meglumine?
The CAS number is 6284-40-8.
3. What is the molecular formula of Meglumine?
Its molecular formula is C₇H₁₇NO₅.
4. What is the molecular weight of Meglumine?
Its molecular weight is approximately 195.21 g/mol.
5. What is another name for Meglumine?
Common synonyms include N-Methyl-D-glucamine, Methylglucamine and 1-Deoxy-1-(methylamino)-D-glucitol.
6. What is the pharmaceutical use of Meglumine?
It is used in pharmaceutical salt formation and selected diagnostic contrast-media formulations.
7. Is Meglumine listed in USP?
Yes. Meglumine has a USP-NF monograph.
8. What is the USP assay specification for Meglumine?
The USP monograph specifies 99.0%–100.5%, calculated on the dried basis.
9. What is the appearance of Meglumine?
It is described as a white crystalline powder.
10. Is Meglumine soluble in water?
Yes. It is described as freely soluble in water.
11. What quality tests are relevant to Meglumine USP?
Relevant tests include identification, assay, residue on ignition, absence of reducing substances, and completeness and color of solution.
12. What documents should be checked before purchasing Meglumine USP?
Review the current USP specification, batch-specific COA, safety data sheet and applicable quality documentation.
| Parameter | Specification |
|---|---|
| Appearance | White crystalline powder |
| Identification | HPLC & IR compliant |
| Assay (HPLC) | 99.0–100.5% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.1% |
| Heavy Metals | NMT 20 ppm |
| pH (1% Solution) | 11.0–12.0 |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 0.20% |
| Water Content | NMT 0.5% |
| Specific Rotation | −15.7° to −17.3° |
| Solubility | Freely soluble in water |